Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2006 1
2007 1
2008 1
2009 1
2011 3
2012 4
2013 3
2014 4
2015 1
2016 1
2017 4
2018 6
2019 6
2020 14
2021 11
2022 14
2023 21
2024 15
2025 20
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean martos j[au] (127 results)?
Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease.
Vakrakou AG, Karachaliou E, Chroni E, Zouvelou V, Tzanetakos D, Salakou S, Papadopoulou M, Tzartos S, Voumvourakis K, Kilidireas C, Giannopoulos S, Tsivgoulis G, Tzartos J. Vakrakou AG, et al. Among authors: tzartos j. Front Immunol. 2023 Jul 26;14:1212757. doi: 10.3389/fimmu.2023.1212757. eCollection 2023. Front Immunol. 2023. PMID: 37564637 Free PMC article. Review.
Ravulizumab and Efgartigimod in Myasthenia Gravis: A Real-World Study.
Stascheit F, Sousa CDF, Aigner A, Behrens M, Keller CW, Klotz L, Lehnerer S, Stein M, Herdick M, Doksani P, Gerischer LM, Hoffmann S, Lazaridis K, Tzartos J, Wiendl H, Meisel A, Lünemann JD. Stascheit F, et al. Among authors: tzartos j. Neurol Neuroimmunol Neuroinflamm. 2025 Jan;12(1):e200331. doi: 10.1212/NXI.0000000000200331. Epub 2024 Nov 27. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 39602677 Free PMC article.
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis.
Abdelhak A, Bachhuber F, Ning K, Benkert P, John Boscardin W, Maleska Maceski A, Schaedelin S, Achtnichts L, Finkener S, Lalive PH, Uginet M, Pot C, Du Pasquier R, Hoepner R, Chan A, Gobbi C, Zecca C, Müller S, Roth P, Granziera C, Chitnis T, Madill E, Weiner HL, Green AJ, Hauser SL, Cree BA, Kümpfel T, Havla J, Skripuletz T, Gingele S, Senel M, Vardakas I, Taranu D, Ziemann U, Kowarik MC, Kleiter I, Hoshi MM, Zettl UK, Haarmann A, Thebault S, Freedman MS, Bergman HP, Iacobaeus E, Khademi M, Ferraro D, Cardi M, Mariotto S, Comabella M, Montalban X, Vilaseca-Jolonch A, Strijbis EM, Wessels MH, Killestein J, Hemmer B, Held F, Sellebjerg F, Højsgaard Chow H, Alvarez-Lafuente R, Domínguez-Mozo MI, Hegen H, Berek K, Deisenhammer F, Thouvenot E, Agherbi H, Rejdak K, Gąsior M, Tzanetakos D, Tzartos JS, Sormani MP, Dujmovic Basuroski I, Arrambide G, Khalil M, Piehl F, Teunissen CE, Kuhle J, Tumani H. Abdelhak A, et al. Among authors: tzartos js. J Neurol Neurosurg Psychiatry. 2025 Oct 15;96(11):1046-1052. doi: 10.1136/jnnp-2025-335831. J Neurol Neurosurg Psychiatry. 2025. PMID: 40506119
Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview.
Delaby C, Ladang A, Martinez-Yriarte J, Zecca C, Logroscino G, Körtvelyessy P, Tumani H, Parchi P, Quadrio I, Hart M, Olsen DA, Alcolea D, Blennow K, Fortea J, Lleo A, Algeciras-Schimnich A, Ayrignac X, Bedel A, Santos GAA, Borelli W, Bouaziz-Amar E, Baldeiras I, Bigot-Corbel E, Bjerke M, Carretero Perez M, Casoli T, Chabrashvili T, Chapman MD, Cusato J, Dursun E, Fourier A, Galimberti D, Gezen-Ak D, Gordon BA, Gouju J, de Las Heras Florez S, Hernandez Sanchez J, Herwerth M, Imperiale D, Kaczorowski F, Kasuga K, Keshavan A, Khalil M, Kuhle J, Leithner C, Lewczuk P, Letournel F, Tsolaki M, Giuffrè GM, Blanc MC, Mroczko B, Martínez Rodríguez JE, Musso G, Kulczynska-Przybik A, Nogueira L, Paquet C, Baiardi S, Gaetani L, Parnetti L, Perez Garay R, Poesen K, Quillard-Muraine M, Rodriguez Borja E, Schraen S, Terracciano D, Bachhuber F, Halbgebauer S, Tzartos S, Tzartos J, Unterwalder N, Vermunt L, Wellington CL, Zetterberg H, Teunissen C, Lehmann S. Delaby C, et al. Among authors: tzartos j. Alzheimers Dement. 2025 Jun;21(6):e70343. doi: 10.1002/alz.70343. Alzheimers Dement. 2025. PMID: 40551293 Free PMC article.
Autoimmunity to neuronal nicotinic acetylcholine receptors.
Pechlivanidou M, Ninou E, Karagiorgou K, Tsantila A, Mantegazza R, Francesca A, Furlan R, Dudeck L, Steiner J, Tzartos J, Tzartos S. Pechlivanidou M, et al. Among authors: tzartos j. Pharmacol Res. 2023 Jun;192:106790. doi: 10.1016/j.phrs.2023.106790. Epub 2023 May 9. Pharmacol Res. 2023. PMID: 37164280 Free article. Review.
PheWAS and cross-disorder analysis reveal genetic architecture, pleiotropic loci and phenotypic correlations across 11 autoimmune disorders.
Topaloudi A, Jain P, Martinez MB, Bryant JK, Reynolds G, Zagoriti Z, Lagoumintzis G, Zamba-Papanicolaou E, Tzartos J, Poulas K, Kleopa KA, Tzartos S, Georgitsi M, Drineas P, Paschou P. Topaloudi A, et al. Among authors: tzartos j. Front Immunol. 2023 Sep 21;14:1147573. doi: 10.3389/fimmu.2023.1147573. eCollection 2023. Front Immunol. 2023. PMID: 37809097 Free PMC article.
Neuronal nicotinic acetylcholine receptor antibodies in autoimmune central nervous system disorders.
Pechlivanidou M, Vakrakou AG, Karagiorgou K, Tüzün E, Karachaliou E, Chroni E, Afrantou T, Grigoriadis N, Argyropoulou C, Paschalidis N, Şanlı E, Tsantila A, Dandoulaki M, Ninou EI, Zisimopoulou P, Mantegazza R, Andreetta F, Dudeck L, Steiner J, Lindstrom JM, Tzanetakos D, Voumvourakis K, Giannopoulos S, Tsivgoulis G, Tzartos SJ, Tzartos J. Pechlivanidou M, et al. Among authors: tzartos j. Front Immunol. 2024 May 28;15:1388998. doi: 10.3389/fimmu.2024.1388998. eCollection 2024. Front Immunol. 2024. PMID: 38863705 Free PMC article.
Subunit-Specific Immunodominance in Clinically Distinct Populations With AChR+ Myasthenia Gravis: A Multiparametric Cross-Sectional Analysis.
Oved K, Denkberg G, Pinzur L, Chroni E, Zouvelou V, Arman I, Mazor RD, Reef S, Harel O, Ntoukaki E, Pechlivanidou M, Ninou E, Tzanetakos D, Salakou S, Chondrogianni M, Daponte A, Rentzos M, Parisis D, Zamba-Papanicolaou E, Pantzaris M, Kleopa KA, Dardiotis E, Vadikolias K, Heliopoulos I, Koutsouraki E, Voumvourakis KI, Konitsiotis S, Giannopoulos S, Grigoriadis NC, Kab T, Friedman Y, Hellmann MA, Alon T, Olmer L, Tsivgoulis G, Lazaridis K, Wilf-Yarkoni A, Tzartos J, Tzartos S. Oved K, et al. Among authors: tzartos j. Neurology. 2025 Oct;105(8):e214150. doi: 10.1212/WNL.0000000000214150. Epub 2025 Sep 29. Neurology. 2025. PMID: 41021867 Free PMC article.
118 results